Home Sulfos N-Phenylmethanesulfonamide

N-Phenylmethanesulfonamide

CAS No.:
1197-22-4
Catalog Number:
AG000PGW
Molecular Formula:
C7H9NO2S
Molecular Weight:
171.2169
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$13
- +
5g
98%
In Stock USA
United States
$19
- +
25g
98%
In Stock USA
United States
$69
- +
100g
98%
In Stock USA
United States
$207
- +
500g
98%
In Stock USA
United States
$744
- +
Product Description
Catalog Number:
AG000PGW
Chemical Name:
N-Phenylmethanesulfonamide
CAS Number:
1197-22-4
Molecular Formula:
C7H9NO2S
Molecular Weight:
171.2169
MDL Number:
MFCD00043782
IUPAC Name:
N-phenylmethanesulfonamide
InChI:
InChI=1S/C7H9NO2S/c1-11(9,10)8-7-5-3-2-4-6-7/h2-6,8H,1H3
InChI Key:
LBTPIFQNEKOAIM-UHFFFAOYSA-N
SMILES:
CS(=O)(=O)Nc1ccccc1
EC Number:
601-626-2
NSC Number:
11329
Properties
Complexity:
199  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
171.035g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
171.214g/mol
Monoisotopic Mass:
171.035g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
54.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9  
Literature
Title Journal
Iguratimod: a new disease-modifying antirheumatic drug. Drugs of today (Barcelona, Spain : 1998) 20120901
Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes. Bioorganic & medicinal chemistry 20120715
Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. TheScientificWorldJournal 20120101
Pharmacological management of atrial fibrillation: one, none, one hundred thousand. Cardiology research and practice 20110101
In silico analysis of conformational changes induced by mutation of aromatic binding residues: consequences for drug binding in the hERG K+ channel. PloS one 20110101
Stereoselective Inhibition of the hERG1 Potassium Channel. Frontiers in pharmacology 20100101
Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel. Biochemical pharmacology 20090515
Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists. Bioorganic & medicinal chemistry 20090115
Discovery of a novel activator of KCNQ1-KCNE1 K channel complexes. PloS one 20090101
N-(4-Chloro-2-nitro-phen-yl)methane-sulfonamide. Acta crystallographica. Section E, Structure reports online 20081001
Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. Cardiology journal 20080101
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Biochemical pharmacology 20070801
Synthesis and biological evaluation of benzopyran analogues bearing class III antiarrhythmic pharmacophores. Bioorganic & medicinal chemistry 20061001
Expression and functional phenotype of mouse ERG K+ channels in the inner ear: potential role in K+ regulation in the inner ear. The Journal of neuroscience : the official journal of the Society for Neuroscience 20050921
Structural determinants of HERG channel block by clofilium and ibutilide. Molecular pharmacology 20040801
A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. American journal of physiology. Heart and circulatory physiology 20040501
Acceleration of human myoblast fusion by depolarization: graded Ca2+ signals involved. Development (Cambridge, England) 20030801
Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency. Cardiovascular research 20030301
Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels. Molecular pharmacology 20011201
Effects of the class III antiarrhythmic agent dofetilide (UK-68,798) on L-type calcium current from rabbit ventricular myocytes. The Journal of pharmacy and pharmacology 20011201
An amino acid residue whose change by mutation affects drug binding to the HERG channel. FEBS letters 20011012
Properties